Results

Total Results: 685 records

Showing results for "cardiovascular".
Users also searched for: statin

101. Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/effect-dietary-digestible/research

102. Comparative Effectiveness of Dietary Supplement Versus No Dietary Supplement Use in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/dietary-supplements/research-protocol

103. Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
     October 07, 2011 - Please add, “… reduce cardiovascular death and to reduce heart failure hospitalizations” to be consistent … It is nowhere near long enough to assess diabetes, cardiovascular events or mortality. … They should also include studies that can meaningfully examine cardiovascular/cerebrovascular event … The key questions 1 and 2 specifically examine cardiovascular events and adverse events between drug … For instance, literature suggests that both ARBs and ACEIs may provide similar cardiovascular protective

104. CER 222: Evidence Summary: Achieving Health Equity in Preventive Services (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-evidence-summary-health-equity.pdf
     January 01, 2020 - of Review To summarize research on achieving health equity in 10 preventive services for cancer, cardiovascular … evidence review summarizes research on achieving health equity in 10 preventive services for cancer, cardiovascular … equity in preventive services related to three high-burden diseases in the United States: cancer, cardiovascular … disease Aspirin use to prevent cardiovascular disease and colorectal cancer: preventive medication … bAlso relevant to cardiovascular disease prevention.

105. Rapid Response_Linking Dental Services to Treatment Outcomes for Chronic Kidney Disease: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
     November 01, 2024 - Additionally, CKD is increasing in prevalence faster than diabetes, cardiovascular disease, stroke and … Events Outcomes reported in the cohort studies relating to cardiovascular (CV) events include time … Four cohort studies22,35–37 assessed the incidence of cardiovascular mortality in patients with CKD … Outcomes: There is insufficient evidence for benefit to patients regarding cardiovascular outcomes … cohort studies, all high quality) that cardiovascular disease, cardiovascular events, strokes, congestive

106. Developing and Piloting a Tool To Create Dot Plots To Summarize Pooled Data for Multiple Outcomes in Systematic Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/dot-plots-methods.pdf
     October 01, 2021 - pilot we used pooled data for statins versus placebo or no statin and risk of all-cause mortality, cardiovascular … stroke (fatal or nonfatal), myocardial infarction (fatal or nonfatal), revascularization, composite cardiovascular … alanine transaminase; AST = aspartate aminotransferase; CI = confidence interval; Ctrl = control; CV = cardiovascular … Abbreviations: AE = adverse event; ALT = alanine aminotransferase; AST = aspartate aminotransferase; CV = cardiovascular … Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review

107. Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/polyunsaturated-fatty/protocol

108. Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/mental-illness-heart/research

109. Strategies To Improve Cardiovascular Risk Factors in People With Serious Mental Illness: A Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/mental-illness-heart/research-protocol

110. White Paper_Supplementing Systematic Review Findings With Healthcare System Data: Pilot Projects From the Agency for Healthcare Research and Quality Evidence-based Practice Center Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pilot-projects-supplementing-white-paper.pdf
     December 01, 2024 - Mayo Clinic Use of Triptans for Migraines: Patients with or at Risk of Cardiovascular Disease … Migraine8 Improve applicability of evidence • Triptans increase the risk of major adverse cardiovascular … events in patients with prior cardiovascular disease or those who have more tan two risk factors … events in patients with elevated cardiovascular risk and are not associated with worse pregnancy … This project showed that triptans increased major adverse cardiovascular events in patients at risk,

111. Heart-Failure-Natriuretic-Peptide Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
     November 01, 2013 - The reviews also found that BNP and NT-proBNP could add useful information to the standard cardiovascular … The outcome of hospitalization and the composite outcome of all-cause mortality and cardiovascular … For cardiovascular mortality, the evidence in 17 publications also suggests a positive association … death or cardiovascular hospitalization,171 congestion score,171 and worsening of HF.170,176 Only … Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.

112. Angina-Heart-Attack-Treatments Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
     January 01, 2014 - hospitalization for UA/NSTEMI and continued for long-term management has been shown to reduce future cardiovascular … conservative approach consists of using different anticoagulants and oral antiplatelets to improve cardiovascular … Final outcomes considered include all-cause death, cardiovascular-related death, nonfatal myocardial … For some studies, we treated total mortality and cardiovascular mortality as essentially similar, since … the event rates of cardiovascular mortality usually dominate the event rates for total mortality.

113. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
     January 01, 2015 - For point 2, we have added absolute risk differences for long-term mortality and cardiovascular outcomes … The former specifically addresses the relative long-term effectiveness (cardiovascular disease outcomes … TEP Reviewer #5 Executive Summary Cardiovascular mortality and morbidity/Table C. … Metformin may not reduce cardiovascular risk or allcause mortality. Evid Based Med. 2013182e13. … We did consider death, cardiovascular disease mortality, and cardiovascular disease events as direct

114. S143 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
     October 01, 2007 - and substantial difference with respect to other variables (such as lipid-related laboratory tests or cardiovascular … disease-related prescriptions 0.51 0.53 �0.09 0.51 0.51 0.94 Mean no. cardiovascular disease-related … physician visits in the past year 0.96 0.54 �0.01 0.74 0.83 0.12 Mean no. cardiovascular disease-related … diagnoses 0.25 0.17 �0.01 0.21 0.23 0.21 Mean no. cardiovascular disease-related hospitalizations … Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease

115. Renal-Function Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
     June 13, 2013 - without suspected ACS, chronic elevation of cTn identifies patients with CKD at increased risk for cardiovascular … In the absence of myocardial ischemia, there are no specific interventions recommended to reduce cardiovascular … Long-term outcomes (all-cause mortality and major adverse cardiovascular events [MACE] such as subsequent … MI, stroke or cardiovascular death, over at least 1 year of follow-up)? … Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD).

116. Treatment for Restless Legs Syndrome: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
     February 01, 2013 - effect of RLS-related chronic sleep deprivation on cardiovascular health? … effect of RLS-related chronic sleep deprivation on cardiovascular health? … effect of RLS-related chronic sleep deprivation on cardiovascular health? … effect of RLS-related chronic sleep deprivation on cardiovascular health? … • Is RLS a risk factor for cardiovascular disease and other health conditions?

117. Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting-future_research.pdf
     January 01, 2014 - Catheterization & Cardiovascular Diagnosis. 1998 Aug;44(4):380-86. PMID: 9716200. 8. … Jacc: Cardiovascular Interventions 4(9):974-81, 2011 Sep. PMID: 21939937. 10. … Scandinavian Cardiovascular Journal. 2001 Mar;35(2):80-85. PMID: 11405501. 16. … Jacc: Cardiovascular Interventions. 2010 Aug; 3(8):812-17. PMID: 20723852. 27. … Circulation: Cardiovascular Interventions. 2009 Jun;2(3):167-77. PMID: 20031713. 33.

118. Acs-Pci-Adjunctive-Devices Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_surveillance.pdf
     April 01, 2013 - Journal of Cardiology, Journal of the American College of Cardiology, Circulation, Catherization and Cardiovascular … of date based on the new RCT Legend: CABG: Coronary Artery Bypass Grafting; MACE: Major Adverse Cardiovascular … Catheterization & Cardiovascular Interventions. 2012 May 1;79(6):870-7. PMID: 21735533. 6. … catheterization & cardiovascular interventions.jn. 62. American heart journal.jn. 63. … Do Not Know Conclusion #1 In the catheter aspiration trials, the risks of major adverse cardiovascular

119. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/presentation.ppt
     August 01, 2009 - Effects of statins on nonlipid serum markers associated with cardiovascular disease. … Effects of Omega-3 Fatty Acids on Cardiovascular Disease. … Effects of Omega-3 Fatty Acids on Cardiovascular Disease. … Effects of statins on nonlipid serum markers associated with cardiovascular disease. … Effects of Omega-3 Fatty Acids on Cardiovascular Disease.

120. Research Protocol: Diabetes Medications for Adults With Type 2 Diabetes: An Update Focused on Monotherapy and Add-On Therapy to Metformin (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
     January 01, 2015 - Diabetes increases the risk of cardiovascular-related death nearly two-fold and is the leading cause … While the FDA has become stricter regarding pre- and post-approval evaluation of cardiovascular risk … comorbid conditions: ESLD, ESRD, cancer, new onset diabetes after organ transplant, or a recent cardiovascular … Diabetes Mellitus - Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes … Results of a reevaluation of cardiovascular outcomes in the RECORD trial.